Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (370)	8/12/2000 12:37:15 AM
From: Mark Bong	Read Replies (1) of 496

Analyst Recommendations? "CIBC World Markets said on Friday that it is cutting its rating on Guilford from strong buy to hold" This Friday's Business Week: "Analyst Matt Geller of CIBC World Markets is impressed by Guilford's neurological compounds. ''They have the potential to revolutionize the treatment of neurological disorders,'' says Geller, who rates the stock a ''strong buy.'' I am really happy that I follow my own counsel on stock selections and rely on intelligent friends rather than analysts. I make many mistakes, some of them pretty dumb, but following analysts recommendations would have cost me a lot more money than my own mistakes. I continue to be amazed when companies receive downgrades at the same time that meaningful good news has been released. Maybe the SEC should require more meaningful disclosure rules for analysts so that the viewing public could see their firms historical trading activity (after a reasonable timeframe) and compare it to their public buy/hold/sell recommendations. Oops, I forgot, there were only a few hundred sell recommendations last year compared with the thousands of buys and holds. Have a good weekend.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next